News

Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced ...
Players intrigued by the premise might be searching for the platforms Rematch will release on, and whether they include ...